Literature DB >> 29463649

Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.

Tali Shalom-Barak1, Jaclyn Liersemann1, Babak Memari2, Lawrence Flechner3, Caitlin E Devor1, Tiffany M Bernardo1, Suyeon Kim1, Nobuyuki Matsumoto4, Scott L Friedman5, Ronald M Evans3, John H White2, Yaacov Barak6.   

Abstract

The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is an essential regulator of placental development. To gain deeper insights into placental PPARγ signaling, we dissected its regulation of the Muc1 promoter. We find that, unlike prototypic target activation by heterodimeric receptors, which is either stimulated by or refractory to retinoid X receptor (RXR) ligands (rexinoids), the induction of Muc1 by liganded PPARγ requires RXRα but is inhibited by rexinoids. We demonstrate that this inhibition is mediated by the activation function 2 (AF2) domain of RXRα and that Muc1 activation entails altered AF2 structures of both PPARγ and RXRα. This unique regulation of Muc1 reflects specific coactivation of PPARγ-RXRα heterodimers by the transcription cofactor ligand-dependent corepressor (LCoR), corroborated by significant downregulation of Muc1 in Lcor-null placentas. LCoR interacts with PPARγ and RXRα in a synergistic fashion via adjacent noncanonical protein motifs, and the AF2 domain of ligand-bound RXRα inhibits this interaction. We further identify the transcription factor Krüppel-like factor 6 (KLF6) as a critical regulator of placental development and a component of Muc1 regulation in cooperation with PPARγ, RXRα, and LCoR. Combined, these studies reveal new principles and players in nuclear receptor function in general and placental PPARγ signaling in particular.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  KLF6; LCoR; PPARgamma; RXR; coactivators; rexinoids; transcription regulation

Mesh:

Substances:

Year:  2018        PMID: 29463649      PMCID: PMC5902596          DOI: 10.1128/MCB.00107-17

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.

Authors:  I G Schulman; G Shao; R A Heyman
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

Review 3.  9-cis retinoic acid signaling: changing partners causes some excitement.

Authors:  B P Leblanc; H G Stunnenberg
Journal:  Genes Dev       Date:  1995-08-01       Impact factor: 11.361

4.  Activation and repression by nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states.

Authors:  I G Schulman; H Juguilon; R M Evans
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses.

Authors:  V Sapin; P Dollé; C Hindelang; P Kastner; P Chambon
Journal:  Dev Biol       Date:  1997-11-01       Impact factor: 3.582

6.  A signature motif in transcriptional co-activators mediates binding to nuclear receptors.

Authors:  D M Heery; E Kalkhoven; S Hoare; M G Parker
Journal:  Nature       Date:  1997-06-12       Impact factor: 49.962

7.  Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.

Authors:  R Mukherjee; P J Davies; D L Crombie; E D Bischoff; R M Cesario; L Jow; L G Hamann; M F Boehm; C E Mondon; A M Nadzan; J R Paterniti; R A Heyman
Journal:  Nature       Date:  1997-03-27       Impact factor: 49.962

8.  Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network.

Authors:  Tali Shalom-Barak; Xiaowen Zhang; Tianjiao Chu; W Timothy Schaiff; Janardan K Reddy; Jianming Xu; Yoel Sadovsky; Yaacov Barak
Journal:  Dev Biol       Date:  2012-08-29       Impact factor: 3.582

9.  Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor.

Authors:  P Tontonoz; E Hu; B M Spiegelman
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing.

Authors:  Dirk Heckl; Monika S Kowalczyk; David Yudovich; Roger Belizaire; Rishi V Puram; Marie E McConkey; Anne Thielke; Jon C Aster; Aviv Regev; Benjamin L Ebert
Journal:  Nat Biotechnol       Date:  2014-06-22       Impact factor: 54.908

View more
  4 in total

Review 1.  Nuclear Receptor Coregulators in Hormone-Dependent Cancers.

Authors:  Hedieh Jafari; Shahid Hussain; Moray J Campbell
Journal:  Cancers (Basel)       Date:  2022-05-13       Impact factor: 6.575

2.  Inferred Causal Mechanisms of Persistent FMDV Infection in Cattle from Differential Gene Expression in the Nasopharyngeal Mucosa.

Authors:  James J Zhu; Carolina Stenfeldt; Elizabeth A Bishop; Jessica A Canter; Michael Eschbaumer; Luis L Rodriguez; Jonathan Arzt
Journal:  Pathogens       Date:  2022-07-22

3.  Regulation of LCoR and RIP140 expression in cervical intraepithelial neoplasia and correlation with CIN progression and dedifferentiation.

Authors:  Tilman L R Vogelsang; Elisa Schmoeckel; Christina Kuhn; Thomas Blankenstein; Mina Temelkov; Helene Heidegger; Theresa Maria Kolben; Thomas Kolben; Sven Mahner; Doris Mayr; Udo Jeschke; Aurelia Vattai
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-10       Impact factor: 4.553

4.  Transcriptomic Profiling of Canine Atrial Fibrillation Models After One Week of Sustained Arrhythmia.

Authors:  Francis J A Leblanc; Faezeh Vahdati Hassani; Laura Liesinger; Xiaoyan Qi; Patrice Naud; Ruth Birner-Gruenberger; Guillaume Lettre; Stanley Nattel
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-07-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.